Omicron surge and the future of COVID-19 vaccinations
Medical Journal of Indonesia · 2022
DOI: 10.13181/mji.bc.226066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Indonesia, 2022. Verfasst von Erlina Burhan und 1 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The global surge of Omicron has caused significant concern. Omicron has caused new wave of infections in nations with adequate vaccine coverage. Omicron has around 30 mutations that are similar to the previous variant of concerns, possibly decreasing vaccine effectiveness (VE). Hence, the emergence of Omicron is predicted to be a significant public health challenge and may alter the future of COVID-19 vaccinations. Furthermore, other issues may affect vaccine policy in the future such as the never-ending vaccine inequity, waning immunity of current COVID-19 vaccines, decreasing VE against new emerging strains, and new findings regarding hybrid immunity. This literature review aimed to explore the possible steps forward using the most updated knowledge on COVID-19 vaccines and Omicron.
Zitieren
APA
Burhan, E., & Rachmadi, R. A. (2022). Omicron surge and the future of COVID-19 vaccinations. Medical Journal of Indonesia. https://doi.org/10.13181/mji.bc.226066
Vancouver
Burhan E, Rachmadi RA. Omicron surge and the future of COVID-19 vaccinations. Medical Journal of Indonesia. 2022. doi:10.13181/mji.bc.226066
BibTeX
@article{Burhan2022,
author = {Burhan, Erlina and Rachmadi, Rizky Abi},
title = {Omicron surge and the future of COVID-19 vaccinations},
journal = {Medical Journal of Indonesia},
year = {2022},
doi = {10.13181/mji.bc.226066}
}
EUVIMED